New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails
Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.
Nearly €20 Million to Drive Innovation in Imaging Technology
A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale Research Infrastructures program. The consortium, known as AMICE (Advanced Multimodal Imaging Centers), will invest over the next decade in advancing and refining imaging technologies that are essential for cutting-edge biomedical research.
Screening reduces prostate cancer mortality, even after more than twenty years
A prostate cancer screening program can reduce prostate cancer mortality, even in the long term. That is the take-away from research conducted by Erasmus MC in a large European group of screened men. ‘The longer the follow-up, the more reliable the results.’
Biomarker may predict Parkinson’s disease progression
Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely. ’
New Erasmus MC Subsidiary Develops Personalized Immunotherapy
Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.
Scientists at Erasmus MC have discovered that von Willebrand disease, the most common inherited bleeding disorder, is not always caused by a genetic defect in the von Willebrand factor gene. Defects in the mechanisms that control secretion of this hemostatic protein can also cause von Willebrand disease, they show.
Zhenyu wants to know how our brains control movements
Picking up a cup or putting one foot in front of the other: even the simplest movements require a lot of calculations from our brains. Scientist Zhenyu Gao wants to know how this works in the brain. He challenges traditional ideas in the process. ‘Brain parts are not separate lego blocks.’
Integrating immune cells to organoids opens doors for viral research
Scientists at Erasmus MC have succeeded in adding immune cells to organoids of the intestine and liver. This makes these mini-organs even more suitable for research into viral diseases, without the need for laboratory animals.
Discovery of a new syndrome brings answers to hundreds of patients with developmental delay
The discovery of a new syndrome brings an end to the search for a diagnosis for hundreds of patients with an unexplained developmental disorder. “A diagnosis means recognition and acknowledgment.”
Human brain slices: the ‘missing piece’ for virus research
Scientists at Erasmus MC have succeeded in keeping slices of human brain tissue alive in the laboratory for at least two weeks. This opens new doors for research, for example, into viruses that infect the brain.
More efficient and effective healthcare for women could save billions
According to the latest report of the World Economic Forum, at least €7.6 billion in healthcare costs could be saved in the Netherlands if women receive the effective care they need. However, this requires investment in the diagnosis and treatment of women. The newly established Netherlands Women’s Health Research & Innovation Center at Erasmus MC […]
